All Biotech News

List of articles in category All Biotech News
Title	Published Date
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever	12/11/2018
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors	12/07/2018
Shuwen Biotech Wins at the 7th Annual China Innovation and Entrepreneurship Competition	12/07/2018
Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting	12/05/2018
Dr. Irina Buhimschi Joins Shuwen Biotech as a Scientific Advisor	12/04/2018
First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring	12/03/2018
BioNTech: MammaTyper® Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer (BC)	11/28/2018
Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104	11/26/2018
Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting	11/21/2018
Restoring Sight: Clinical Progress Towards Australia’s Bionic Eye	11/19/2018
Elpis Biomed Wins Cambridge Start-Up of the Year	11/16/2018
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics	11/15/2018
Top Oncologist, Dr Samuel Fourie, Joins Advisory Board of AzarGen Biotechnologies	11/14/2018
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round	11/12/2018
RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders	11/12/2018
Icosabutate Latest Data Shows Direct and Potent Anti-Fibrotic Effect in Both Differentiated Rodent NASH Models and Human Stellate Cells	11/09/2018
T3 Pharmaceuticals Wins Prestigious Falling Walls Venture Award for Its Bacterial Cancer Therapy	11/09/2018
Selvita to Present New Data from SEL120 Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics	11/08/2018
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations	11/08/2018
ProBioGen Announces Successful Bispecific GlymaxX® Development Project for Zymeworks	11/06/2018
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters' Option	11/05/2018
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018	10/31/2018
Orchard Therapeutics Announces Pricing of Initial Public Offering	10/31/2018
Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug Discovery	10/25/2018
Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer	10/25/2018
Vetter Further Expands Secondary Packaging	10/24/2018
Change of Company Name: VTU Technology is now VALIDOGEN	10/22/2018
Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure	10/22/2018
apceth Biopharma Presents Positive Data Demonstrating Efficacy of apceth-201 in Preclinial Models of Acute GvHD	10/19/2018
IME Medical Electrospinning Enters into Development Cooperation with Leading Chinese Medical Devices Company Amor Medical	10/11/2018

Page 28 of 84